COPD combo therapy gets PBS listing

A once-daily dual bronchodilator to treat chronic obstructive pulmonary disease has been listed on the PBS.

The Ultibro Breezhaler 110/50 combines 110 micrograms of the long acting beta adrenergic agonist (LABA) indacaterol maleate and 50 micrograms of the long acting muscarinic antagonist (LAMA) glycopyrronium bromide into one device.

The device is in line with international guidelines developed by the